Myelodysplastic Syndrome (MDS)
Clinical Research STudy
Enjoy the moments that matter.
Myelodysplastic syndrome (MDS) refers to when the red blood cells develop abnormally and the body may not have enough new blood cells to work properly. MDS can occur when blood cells and bone marrow become damaged and stop working properly, but the reason why is still unknown.
Local doctors are recruiting participants for a clinical research study to test the effectiveness and safety of an investigational medication for subjects with MDS. If you or a loved one have been diagnosed with MDS, consider participating in this study and help the future of medicine and your health options.
To qualify for this study, you must:
- Be at least 19 years old
- Have MDS or a high-risk MDS
- Be able to receive IV decitabine
Study-related care and medication may be provided at no cost to qualified participants. Reimbursement for time and travel may also be provided.